AJGP
HOME HELP FEEDBACK SUBSCRIPTIONS ALL ISSUES SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a Colleague
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kraemer, H. C.
Right arrow Articles by Arndt, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kraemer, H. C.
Right arrow Articles by Arndt, S.
Am J Geriatr Psychiatry 10:653-659, December 2002
© 2002 American Association for Geriatric Psychiatry


Special Article

Biomarkers in Psychiatry

Methodological Issues

Helena Chmura Kraemer, Ph.D., Susan K. Schultz, M.D., and Stephan Arndt, Ph.D.

Received February 11, 2002; revised July 2, 2002; accepted July 9, 2002. From the Department of Psychiatry and Behavioral Sciences, Stanford University, Stanford CA 94305 (HCK), the University of Iowa College of Medicine (SKS), and the Department of Psychiatry, College of Medicine, and Department of Biostatistics, College of Public Health, University of Iowa (SA). Address correspondence to Dr. Kraemer, Department of Psychiatry and Behavioral Sciences, Stanford University, 401 Quarry Road, MC 5717, Stanford, CA 94305. e-mail: HCK{at}stanford.edu

Particularly in psychiatry, biological measures are increasingly sought to detect exposure to toxic agents, to assist in early identification of illness, and to enhance diagnostic certainty, provide prognostic information, and permit the mapping of outcome in a variety of disorders. The authors explore the fundamental criteria necessary to designate a biological measure as a "biomarker" and discuss the potential applications, limitations, and hazards of such markers. Authors discuss methods for establishing the validity of a biomarker. Finally, they convey a word of caution about overinterpreting the clinical or scientific value of any biological measure.

Key Words: Research Techniques • Genetics • Biomarkers




This article has been cited by other articles:


Home page
Schizophr BullHome page
M. L. Phillips and E. Vieta
Identifying Functional Neuroimaging Biomarkers of Bipolar Disorder: Toward DSM-V
Schizophr Bull, July 1, 2007; 33(4): 893 - 904.
[Abstract] [Full Text] [PDF]


Home page
AJGPHome page
B. G. Pollock
Biomarkers: From Bedside to Bench and Back Again
Am J Geriatr Psychiatry, December 1, 2002; 10(6): 644 - 645.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ALL ISSUES SEARCH TABLE OF CONTENTS
Copyright © 2002 American Association for Geriatric Psychiatry